BioMarin Pharmaceutical shares owned by Capital Research Global Investors
Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Capital Research Global Investors
from 13F filings
Historical chart of Capital Research Global Investors investment in BioMarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including BioMarin Pharmaceutical held by Capital Research Global Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioMarin Pharmaceutical by Capital Research Global Investors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $533M | 6.0M | 88.48 |
| 2023-06-30 | $586M | 6.8M | 86.69 |
| 2023-03-31 | $701M | 7.2M | 97.23 |
| 2022-12-31 | $585M | 5.7M | 103.49 |
| 2022-03-31 | $724M | 9.4M | 77.10 |
| 2021-12-31 | $1.1B | 13M | 88.35 |
| 2021-09-30 | $1.4B | 18M | 77.29 |
| 2021-06-30 | $1.8B | 22M | 83.44 |
| 2021-03-31 | $1.7B | 22M | 75.51 |
| 2020-12-31 | $1.9B | 22M | 87.69 |
| 2020-09-30 | $1.7B | 22M | 76.08 |
| 2020-06-30 | $2.7B | 22M | 123.34 |
| 2020-03-31 | $1.9B | 22M | 84.50 |
| 2019-12-31 | $1.9B | 22M | 84.55 |
| 2019-09-30 | $1.5B | 22M | 67.40 |
| 2019-06-30 | $1.7B | 20M | 85.65 |
| 2019-03-31 | $1.6B | 18M | 88.83 |
| 2018-12-31 | $1.6B | 18M | 85.15 |
| 2018-09-30 | $1.9B | 20M | 96.97 |
| 2018-06-30 | $2.0B | 22M | 94.20 |
| 2018-03-31 | $1.7B | 22M | 81.07 |
| 2017-12-31 | $1.9B | 22M | 89.17 |
| 2017-03-31 | $1.7B | 20M | 87.78 |
| 2016-12-31 | $1.6B | 20M | 82.84 |
| 2016-09-30 | $1.9B | 20M | 92.52 |
| 2016-06-30 | $1.2B | 16M | 77.80 |
| 2016-03-31 | $1.3B | 16M | 82.48 |
| 2015-12-31 | $1.9B | 18M | 104.76 |
| 2015-09-30 | $2.0B | 19M | 105.32 |
| 2015-03-31 | $2.4B | 20M | 124.62 |
| 2014-12-31 | $1.9B | 19M | 97.16 |
| 2014-06-30 | $1.1B | 18M | 62.21 |
| 2013-12-31 | $1.2B | 17M | 70.27 |
| 2013-09-30 | $1.3B | 17M | 72.22 |
| 2013-06-30 | $947M | 17M | 55.79 |
More positions owned by Capital Research Global Investors
View all positions for Capital Research Global Investors